Artículos de revistas
Plasmocitoma extramedular. Una rara causa de masa mediastínica
Fecha
2017Registro en:
Rev Med Chile 2017; 145: 812-815
0717-6163
Autor
Quilodrán, Javier A.
Peña, Camila
Valladares, Ximena
Institución
Resumen
Solitary extramedullary plasmacytomas represent 3% of plasma cell neoplasms.
Their most common locations are the upper gastrointestinal and respiratory tract.
We report a 70-year-old male presenting with progressive dyspnea and cough. A
chest radiography showed widened mediastinum. Chest computed tomography
showed a mediastinal mass. A bronchoscopy showed an extrinsic compression
and complete occlusion of the primary bronchus. A self-expandable prosthesis
was installed in left bronchus. A population of plasmacytoid cells was evidenced
in the mass biopsy. Immunohistochemistry revealed CD20+ and CD138+. These
tumor cells stained positively for lambda light chains, but negatively for kappa
chains. Therefore an extramedullary plasmacytoma was diagnosed. A multiple
myeloma was discarded with a normal blood count, serum calcium and creatinine
levels. Serum protein electrophoresis had a monoclonal spike, serum IgG
was 1963 mg/dl. Bone marrow aspiration had 1% of plasma cells. Bone x-rays
were normal. Computed tomographies of the neck, thorax, abdomen and pelvis
ruled out other plasmacytomas. Eight cycles of chemotherapy with thalidomide,
melphalan and prednisone were indicated, obtaining complete remission of
the tumor. The review of the literature shows that mediastinal extramedullary
plasmacytomas are extremely rare. They generally appear in men aged between
50 and 60 years. The treatment of choice is radiotherapy, but given the location
in the present case, chemotherapy was considered the best option. Recurrence
is approximately 10 to 30% and 10% of patients progress to myeloma, thus
requiring close monitoring.